The ANKIB1 Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population of A-549 cells with targeted disruption of the ANKIB1 gene. This knockout model provides a versatile tool for studying the loss-of-function effects of ANKIB1 in a lung adenocarcinoma background. The polyclonal nature ensures representation of diverse editing events within the population, enabling robust functional analyses without the need for clonal isolation.
A-549 cells are a well-characterized human lung adenocarcinoma epithelial cell line, originally derived from a 58-year-old Caucasian male. They exhibit adherent morphology and are widely employed as a model system for human lung adenocarcinoma research. The A-549 cell line retains key features of lung cancer cells, including oncogenic signaling pathway alterations, making it suitable for investigating molecular mechanisms underlying lung tumorigenesis and therapeutic responses.
ANKIB1 functions as a substrate-recognition component of the cullin-RING E3 ubiquitin ligase complex, where it interacts with key components such as CUL4, DDB1, and RBX1, and collaborates with E2 ubiquitin-conjugating enzymes to mediate the ubiquitination and subsequent proteasomal degradation of specific target proteins. Through this activity, ANKIB1 regulates protein turnover and cellular homeostasis. It acts within the ubiquitin-proteasome system, with downstream targets including ubiquitinated substrate proteins and the proteasome, thereby modulating processes such as protein degradation and cell cycle regulation.
In the context of A-549 lung adenocarcinoma cells, ANKIB1-mediated protein ubiquitination may influence pathways critical for cancer cell proliferation, survival, and stress responses. Disruption of ANKIB1 expression allows researchers to dissect its role in modulating the stability of putative oncogenic or tumor-suppressive substrates, offering insights into the dysregulation of protein degradation in lung cancer. This model is particularly valuable for exploring how altered ubiquitin-proteasome system activity contributes to lung adenocarcinoma pathology.
This polyclonal knockout cell population is suitable for a range of experimental applications, including western blotting to assess protein expression changes, ubiquitination assays to evaluate substrate modification, proteasome activity assays, and functional readouts such as cell viability and colony formation assays. It enables detailed functional studies of the ubiquitin-proteasome pathway, protein degradation dynamics, and lung cancer cell biology. For additional technical information or to discuss experimental design, please contact Ascent Research.
